HKIM
MRK icon

Hayek Kallen Investment Management’s Merck MRK Stock Holding History

Hayek Kallen Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Buy
+23,712
New +$2.74M 0.93% 32
2025
Q4 		– Sell
-24,139
Closed -$2.03M – 143
2025
Q3 		$2.03M Sell
24,139
-111
-0.5% -$9.14K 0.64% 39
2025
Q2 		$1.92M Buy
24,250
+491
+2% +$39K 0.65% 38
2025
Q1 		$2.13M Sell
23,759
-1,815
-7% -$169K 0.79% 36
2024
Q4 		$2.54M Sell
25,574
-173
-0.7% -$17.8K 0.92% 31
2024
Q3 		$2.92M Sell
25,747
-52
-0.2% -$6.18K 1.04% 29
2024
Q2 		$3.19M Buy
25,799
+46
+0.2% +$5.92K 1.19% 25
2024
Q1 		$3.4M Buy
25,753
+49
+0.2% +$6.04K 1.3% 28
2023
Q4 		$2.8M Sell
25,704
-118
-0.5% -$12.2K 1.17% 29
2023
Q3 		$2.66M Sell
25,822
-145
-0.6% -$15.6K 1.19% 29
2023
Q2 		$3M Sell
25,967
-125
-0.5% -$14.2K 1.27% 28
2023
Q1 		$2.78M Sell
26,092
-974
-4% -$105K 1.26% 30
2022
Q4 		$3M Sell
27,066
-66
-0.2% -$6.75K 1.38% 26
2022
Q3 		$2.34M Buy
27,132
+23
+0.1% +$2.05K 1.1% 32
2022
Q2 		$2.47M Sell
27,109
-343
-1% -$30.4K 1.08% 32
2022
Q1 		$2.25M Sell
27,452
-189
-0.7% -$14.9K 0.83% 39
2021
Q4 		$2.12M Buy
27,641
+960
+4% +$76.5K 0.76% 40
2021
Q3 		$2M Buy
26,681
+1,225
+5% +$93.2K 0.91% 36
2021
Q2 		$1.98M Sell
25,456
-845
-3% -$62.9K 0.83% 39
2021
Q1 		$1.94M Buy
26,301
+1,121
+4% +$82.7K 0.87% 39
2020
Q4 		$1.97M Buy
25,180
+798
+3% +$61K 0.95% 34
2020
Q3 		$1.93M Buy
24,382
+851
+4% +$66.7K 1.08% 31
2020
Q2 		$1.74M Buy
23,531
+422
+2% +$31.8K 0.98% 36
2020
Q1 		$1.7M Buy
23,109
+860
+4% +$67.6K 1.14% 36
2019
Q4 		$1.93M Buy
22,249
+3,447
+18% +$283K 1.11% 35
2019
Q3 		$1.51M Buy
18,802
+532
+3% +$42.6K 0.94% 37
2019
Q2 		$1.46M Buy
18,270
+1,234
+7% +$94.5K 0.93% 37
2019
Q1 		$1.35M Buy
17,036
+2,941
+21% +$220K 0.88% 37
2018
Q4 		$1.03M Sell
14,095
-268
-2% -$18.9K 0.74% 36
2018
Q3 		$972K Sell
14,363
-262
-2% -$16.7K 0.62% 42
2018
Q2 		$847K Sell
14,625
-675
-4% -$38.1K 0.59% 41
2018
Q1 		$795K Buy
15,300
+1,471
+11% +$79.4K 0.55% 42
2017
Q4 		$742K Buy
13,829
+808
+6% +$44.8K 0.49% 44
2017
Q3 		$796K Buy
13,021
+48
+0.4% +$2.91K 0.55% 42
2017
Q2 		$793K Buy
12,973
+22
+0.2% +$1.34K 0.54% 43
2017
Q1 		$785K Buy
12,951
+48
+0.4% +$2.91K 0.54% 43
2016
Q4 		$725K Sell
12,903
-166
-1% -$9.71K 0.53% 41
2016
Q3 		$778K Buy
13,069
+47
+0.4% +$2.75K 0.56% 42
2016
Q2 		$716K Buy
13,022
+1,072
+9% +$57.1K 0.51% 42
2016
Q1 		$603K Buy
11,950
+3,510
+42% +$172K 0.45% 41
2015
Q4 		$425K Buy
8,440
+2,254
+36% +$114K 0.33% 44
2015
Q3 		$292K Buy
+6,186
New +$329K 0.23% 48
2015
Q2 		– Sell
-6,096
Closed -$334K – 58
2015
Q1 		$334K Buy
6,096
+42
+0.7% +$2.38K 0.25% 48
2014
Q4 		$328K Buy
6,054
+42
+0.7% +$2.34K 0.24% 50
2014
Q3 		$340K Buy
6,012
+43
+0.7% +$2.42K 0.26% 46
2014
Q2 		$330K Buy
5,969
+44
+0.7% +$2.4K 0.25% 51
2014
Q1 		$321K Buy
5,925
+379
+7% +$19.6K 0.26% 49
2013
Q4 		$265K Buy
5,546
+48
+0.9% +$2.19K 0.21% 57
2013
Q3 		$250K Sell
5,498
-341
-6% -$15.6K 0.21% 54
2013
Q2 		$259K Buy
+5,839
New +$261K 0.22% 53

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hayek Kallen Investment Management's MRK Position: Q1 2026 in Review

Hayek Kallen Investment Management opened a new position in Merck (MRK) in Q1 2026: 23,712 shares worth $2.85M. The stake represents 0.93% of the portfolio and ranks #32 among its holdings. This is a return to the name: Hayek Kallen Investment Management previously reported a position in MRK as recently as Q3 2025.

Hayek Kallen Investment Management first reported a position in MRK in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.4M in Q1 2024. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hayek Kallen Investment Management held 23,712 shares of Merck worth $2.85M as of Q1 2026.
  • Merck was a new Hayek Kallen Investment Management position in Q1 2026.
  • Merck made up 0.93% of Hayek Kallen Investment Management's portfolio in Q1 2026, its #32 holding.
  • Hayek Kallen Investment Management first reported a position in Merck in Q2 2013 and has held it in 50 quarters since.
  • Hayek Kallen Investment Management's Merck position peaked at $3.4M in Q1 2024.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hayek Kallen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.